8i Acquisition 2 Corp. and EUDA Health Limited Announce Extension of Due Diligence Review Period Singapore, May 31, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company” or “LAX”) (NASDAQ: LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a...

8i Acquisition 2 Corp. to Combine with EUDA Health Limited to Bring a Leading Digital Health Platform Servicing Southeast Asia to the Public Market EUDA Health is disrupting the multi-trillion-dollar Southeast Asia healthcare industry with its proprietary unified AI platform that makes healthcare affordable, accessible, and personalized across...

8i Acquisition 2 Corp. Announces the Separate Trading of its Ordinary Shares, Warrants and Rights, Commencing December 14, 2021  Singapore, Dec. 13, 2021 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ: LAXXU) (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company...

8i Acquisition 2 Corp. Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Over-Allotment Option Singapore, Nov. 24, 2021 (GLOBE NEWSWIRE) --  8i Acquisition 2 Corp. (NASDAQ: LAXXU) (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company...

8i Acquisition 2 Corp. Announces Pricing of $75 Million Initial Public Offering Singapore, Nov. 22, 2021 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the “Company”), a newly organized blank check company incorporated as a British Virgin Islands business company and led by Chief...